Biotechnology News

September 29, 2014

ATLANTA--(BUSINESS WIRE)--Georgia Bio, UCB Inc., the National Parkinson Foundation, and the Wilkins Parkinson's Foundation invite you to attend an evening celebrating people living with Parkinson's disease Oct. 15 in Atlanta.

September 29, 2014

WINNIPEG, Manitoba--(BUSINESS WIRE)--The Life Science Association of Manitoba engages future innovators to promote careers in the life sciences during National Biotechnology Week.

September 29, 2014

NEW BRIGHTON, Minn.--(BUSINESS WIRE)--Cellectis plant sciences launches its new website

September 29, 2014

SAN ANTONIO--(BUSINESS WIRE)--MD Anderson Cancer Center won 2014 ES Dept. of the Year from Health Facilities Management magazine. Xenex germ-zapping robots help MDACC reduce HAIs by destroying the pathogens that cause infections.

September 29, 2014

BOULDER, Colo.--(BUSINESS WIRE)--NEC Corporation signs agreement with SomaLogic for exclusive Japan marketing rights for SOMAscan assay.

September 29, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group (NYSE MKT: XXII) announced today that Joseph Pandolfino, Founder and CEO of 22nd Century Group, will be the featured guest on September 30 at 11:00 AM (EDT), for the latest insta

September 29, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE:A) today announced a collaboration with scientists at the University of Toronto’s Donnelly Centre for Cellular and Biomolecular Research to produce a comprehensive...

September 29, 2014

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE: OPK) is pleased to lend its support to the legislation introduced in the United States Senate on September 16, 2014 by Senators Jeff Sessions (R-AL) and Barbara Boxer (D-CA) legislating the...

September 29, 2014

SAN DIEGO--(BUSINESS WIRE)--FDA Approves NeuroGenetic Pharmaceuticals to begin clinical trials on NGP 555 compound to treat, prevent Alzheimer's disease.

September 29, 2014

HUBBARD, Ohio--(BUSINESS WIRE)--NanoLogix Inc. mentioned in UNITAID TB Tuberculosis diagnostics technology and market landscape – 3rd edition. The Ohio State University issues purchase order to NanoLogix for lab supplies

September 29, 2014

MENLO PARK, Calif.--(BUSINESS WIRE)--Asterias Biotherapeutics, Inc. (OTCBB: ASTY) announced today that on October 1, 2014 the company will distribute 8,000,000 warrants to purchase common shares of BioTime, Inc. (the “BioTime Warrants”) at a...

September 29, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Strengthens Patent Portfolio with Expansion into B-cell Diseases and Announces Allowance of 98th T-cell Patent

September 29, 2014

MINNEAPOLIS--(BUSINESS WIRE)--Blue Belt Technologies, an orthopedic surgical technology company, today announced the addition Professor David Barrett, Consultant Orthopaedic Surgeon specializing in knee surgery at Southampton University Hospital...

September 29, 2014

GENEVA--(BUSINESS WIRE)--In line with this year’s theme for the annual European Society for Medical Oncology (ESMO) Congress - ‘Precision Medicine in Cancer Care’ - Genomic Health presented results from multiple studies across different cancer...

September 29, 2014

WOBURN, Mass.--(BUSINESS WIRE)--Mobile Heartbeat will be exhibiting at the ANCC National Magnet Conference in Booth #1519, showcasing Mobile Heartbeat CURE, its secure smartphone application enabling clinical communications.

September 29, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE: AGN) announced today that the U.S. Food and Drug Administration (FDA) has approved OZURDEX® (dexamethasone intravitreal implant) 0.7 mg, a sustained-release biodegradable steroid implant,...

September 29, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Vantage Health Announces Appointment of Edward Rollins, Former Advisor to Four U.S. Presidents, to Its Board of Directors

September 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis to present at the International Congress of the World Muscle Society.

September 29, 2014

SAN FRANCISCO--(BUSINESS WIRE)--Today, Jaguar Animal Health, Inc. (“Jaguar”), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, announced the planned...

September 29, 2014

YOKOHAMA, Japan--(BUSINESS WIRE)--ReproCELL Launches Cell Innovation Partners, L.P. with Shinsei Bank, Limited

September 29, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--European Medicines Agency Validates the Marketing Authorization Application for Nivolumab in Non-Small Cell Lung Cancer

September 29, 2014

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. doing business as Sevion Therapeutics ("Sevion" or the "Company") (OTCQB:SNTI) today reported financial results for the fiscal year ended June 30, 2014 (“Fiscal 2014”), and also...

September 29, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--ImmuneXcite, Inc., a biopharmaceutical company focused on developing a next generation immunotherapy platform to generate new targeted immunotherapies for cancer employing a unique neutrophils-initiated immune...

September 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Daniel R Marshak, PhD to its Board of Directors. Dr. Marshak most recently served as Senior Vice President and Chief Scientific...

September 29, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals will present at the 2014 Leerink Rare Disease Roundtable, Bernstein’s Genes as Drugs Event, and the 13th Annual BIO Investor Forum.

September 29, 2014

CAMBRIDGE, Mass. & MADRID--(BUSINESS WIRE)--Tokai Pharmaceuticals Presents Updated Phase 2 Data on Galeterone in Patients with Advanced Prostate Cancer at ESMO 2014

September 29, 2014

IRVINE, Calif.--(BUSINESS WIRE)--The Board of Directors of Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today issued the following statement: There has recently been significant and potentially distracting market speculation regarding...

September 29, 2014

SAN RAFAEL, Calif.--(BUSINESS WIRE)--BioCision Opens Global Headquarters in San Rafael, California

September 29, 2014

MADRID & CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced updated clinical results on its investigational tyrosine kinase inhibitor (TKI), AP26113, in patients with advanced non-small cell lung...

September 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN) will present a corporate overview at the Leerink Partners Rare Disease Roundtable on October 1, 2014 in NYC.

September 29, 2014

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Illinois’ Christopher Rural Health Planning Corporation, a Federally Qualified Health Center (FQHC), has selected eClinicalWorks comprehensive electronic health records (EHR) across its 13 locations.

September 29, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Announces Presentations of Results for CGEN-15001 Supporting Immune Tolerance Induction at International Conference on Immune Tolerance in Amsterdam

September 29, 2014

MODI’IN, Israel--(BUSINESS WIRE)--Exalenz Bioscience (TASE: EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, announced today Lawrence Cohen, CEO...

September 29, 2014

CLEVELAND--(BUSINESS WIRE)--The Ohio Clinical Trials Collaborative (OCTC) will join 100 companies and organizations presenting at the 14th annual Biotech in Europe Forum for Global Partnering and Investment Sept. 30-Oct. 1 in Basel, Switzerland....

September 29, 2014

ATLANTA--(BUSINESS WIRE)--At the 60th Annual ASIS International Seminar and Exhibit, the Bruker Detection division introduces RoadRunner™, an innovative, hand-held explosives and narcotics trace detector with outstanding sensitivity, selectivity...

September 29, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) today announced poster presentations for two Phase 2 clinical studies of tivozanib, one in metastatic colorectal cancer (mCRC) and one in renal cell carcinoma (RCC), at the 2014...

September 29, 2014

BOTHELL, Wash. & OSAKA, Japan--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that patients with Hodgkin lymphoma (HL) who received ADCETRIS (brentuximab vedotin) as...

September 29, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today the second extension to supply Glassia® to Baxter in its strategic agreement...

September 29, 2014

LOS ANGELES--(BUSINESS WIRE)--PBYI announced positive initial data from the ongoing, open label Phase II clinical trial of its investigational drug PB272 (neratinib) for the treatment of patients with NSCLC with HER2 mutations.

September 29, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals Data Presented at ESMO 2014 Congress Show Ablative, Bystander Effects of PV-10

September 29, 2014

GÖTEBORG, Sweden & RADNOR, Pa.--(BUSINESS WIRE)--Cortendo AB (OAX:CORT) Cortendo AB [ticker: CORT on NOTC-A], a biopharmaceutical company developing and commercializing products at the intersection of orphan diseases and endocrinology...

September 29, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck Announces First Presentation of Early Data on the Investigational Use of KEYTRUDA® (pembrolizumab) in Patients with Advanced Bladder Cancer at ESMO 2014

September 29, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--MSD Announces First Presentation of Early Data on the Investigational Use of Pembrolizumab in Patients with Advanced Bladder Cancer at ESMO 2014

September 29, 2014

DARMSTADT, Germany--(BUSINESS WIRE)--Product innovations and geographical expansion drive sustained Merck Consumer Health business growth

September 29, 2014

HARROGATE, England--(BUSINESS WIRE)--Mayor and Mayoress Open Smithers Viscient EU Research Laboratory in Harrogate

September 29, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Positive Phase 3 Data for Opdivo (nivolumab) in Advanced Melanoma Patients Previously Treated with Yervoy (ipilimumab) Presented at the ESMO 2014 Congress; First Presentation of Phase 3 Results.

September 29, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive data from the coBRIM Phase III study. The results showed that people with previously untreated BRAF V600...

September 29, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis Inc. (NASDAQ:EXEL) today announced the positive results from coBRIM, the phase 3 pivotal trial conducted by Exelixis’ collaborator Genentech, a member of the Roche Group, evaluating...